Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-03 Borgeson Blake Director Sale 10b5-1 −40,000 $3.88 $155K 6,068,287
2026-10-06 Borgeson Blake Director Sale 10b5-1 −50,000 $4.84 $242K 6,108,287
2026-09-01 Borgeson Blake Director Sale 10b5-1 −30,000 $3.34 $100K 6,158,287
2026-08-04 Borgeson Blake Director Sale 10b5-1 −30,000 $3.25 $98K 6,188,287
2026-07-07 Borgeson Blake Director Sale 10b5-1 −40,000 $3.96 $159K 6,218,287
2026-06-17 Borgeson Blake Director Grant or award +88,424 6,258,287
2026-06-02 Borgeson Blake Director Sale 10b5-1 −30,000 $3.68 $110K 6,169,863
2026-05-05 Borgeson Blake Director Sale 10b5-1 −30,000 $3.52 $106K 6,199,863
2026-04-07 Borgeson Blake Director Sale 10b5-1 −30,000 $3.10 $93K 6,229,863
2026-03-03 Borgeson Blake Director Sale 10b5-1 −170,000 $3.46 $588K 6,259,863
2026-02-03 Borgeson Blake Director Sale 10b5-1 −220,000 $4.20 $924K 6,429,863
2026-01-06 Borgeson Blake Director Sale 10b5-1 −220,000 $4.36 $959K 6,649,863
2025-12-02 Borgeson Blake Director Sale 10b5-1 −220,000 $4.37 $961K 6,869,863
2025-06-18 Borgeson Blake Director Grant or award +22,016 7,089,863
2025-06-18 Borgeson Blake Director Grant or award · Stock Option (Right to Buy) +44,031 44,031
2025-01-02 Borgeson Blake Director Grant or award +1,734 7,067,847
2024-11-12 Borgeson Blake Director Sale 10b5-1 −11,447 $7.64 $87K 7,066,113
2024-10-29 Borgeson Blake Director Sale 10b5-1 −11,447 $6.72 $77K 7,077,560
2024-10-15 Borgeson Blake Director Sale 10b5-1 −11,447 $6.67 $76K 7,089,007
2024-10-01 Borgeson Blake Director Grant or award +2,026 7,100,454

Page 1 of 2 · 39 trades